These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9262115)

  • 1. Duration of anticoagulant treatment for venous thrombosis.
    Raskob GE
    Curr Opin Pulm Med; 1997 Jul; 3(4):286-90. PubMed ID: 9262115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis.
    Sarasin FP; Bounameaux H
    BMJ; 1998 Jan; 316(7125):95-9. PubMed ID: 9462312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
    N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.
    Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP;
    Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.
    Ridker PM
    Vasc Med; 1998; 3(1):67-73. PubMed ID: 9666536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.
    Eckman MH; Singh SK; Erban JK; Kao G
    Med Decis Making; 2002; 22(2):108-24. PubMed ID: 11958494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent venous thrombosis with factor V Leiden mutation.
    Meenakshi-Sundaram S; Sridhar R; Jithendrian JJ; Durai RN; Arunkumar MJ; Sundar B
    J Assoc Physicians India; 2005 Jul; 53():642-4. PubMed ID: 16190136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
    Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
    N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duration of oral anticoagulant therapy in venous thromboembolism].
    Pinède L
    Rev Med Interne; 2001 Dec; 22(12):1225-36. PubMed ID: 11794893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
    Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
    Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended treatment for venous thromboembolism: how long is long enough?
    Cosmi B; Palareti G
    Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
    Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
    Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in a hospital setting.
    Grau E; Real E; Medrano J; Pastor E; Selfa S
    Thromb Res; 1999 Dec; 96(5):335-41. PubMed ID: 10605948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
    Frazee LA; Chomo DL
    Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.